Correlation Between Assertio Therapeutics and Intra Cellular

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Assertio Therapeutics and Intra Cellular at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Assertio Therapeutics and Intra Cellular into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Assertio Therapeutics and Intra Cellular Therapies, you can compare the effects of market volatilities on Assertio Therapeutics and Intra Cellular and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Assertio Therapeutics with a short position of Intra Cellular. Check out your portfolio center. Please also check ongoing floating volatility patterns of Assertio Therapeutics and Intra Cellular.

Diversification Opportunities for Assertio Therapeutics and Intra Cellular

0.0
  Correlation Coefficient

Pay attention - limited upside

The 3 months correlation between Assertio and Intra is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Assertio Therapeutics and Intra Cellular Therapies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Intra Cellular Therapies and Assertio Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Assertio Therapeutics are associated (or correlated) with Intra Cellular. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Intra Cellular Therapies has no effect on the direction of Assertio Therapeutics i.e., Assertio Therapeutics and Intra Cellular go up and down completely randomly.

Pair Corralation between Assertio Therapeutics and Intra Cellular

If you would invest  61.00  in Assertio Therapeutics on May 6, 2025 and sell it today you would earn a total of  10.02  from holding Assertio Therapeutics or generate 16.43% return on investment over 90 days.
Time Period3 Months [change]
DirectionFlat 
StrengthInsignificant
Accuracy1.59%
ValuesDaily Returns

Assertio Therapeutics  vs.  Intra Cellular Therapies

 Performance 
       Timeline  
Assertio Therapeutics 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Assertio Therapeutics are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively inconsistent basic indicators, Assertio Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.
Intra Cellular Therapies 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Intra Cellular Therapies has generated negative risk-adjusted returns adding no value to investors with long positions. Despite fairly strong fundamental indicators, Intra Cellular is not utilizing all of its potentials. The current stock price confusion, may contribute to short-horizon losses for the traders.

Assertio Therapeutics and Intra Cellular Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Assertio Therapeutics and Intra Cellular

The main advantage of trading using opposite Assertio Therapeutics and Intra Cellular positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Assertio Therapeutics position performs unexpectedly, Intra Cellular can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Intra Cellular will offset losses from the drop in Intra Cellular's long position.
The idea behind Assertio Therapeutics and Intra Cellular Therapies pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Backtesting
Avoid under-diversification and over-optimization by backtesting your portfolios
Portfolio Optimization
Compute new portfolio that will generate highest expected return given your specified tolerance for risk
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation